Home

Paper - Inflammatory disease and the human microbiome

Type: Paper
Authors: Amy D. Proal PhD, Paul J. Albert, and Trevor G Marshall PhD
Publication: Discovery Medicine
Citation:

Inflammatory disease and the human microbiome.
Proal AD, Albert PJ, Marshall TG
Discov Med17p257-65(2014 May)

See also: Full text

Abstract

The human body is a superorganism in which thousands of microbial genomes continually interact with the human genome. A range of physical and neurological inflammatory diseases are now associated with shifts in microbiome composition. Seemingly disparate inflammatory conditions may arise from similar disruption of microbiome homeostasis. Intracellular pathogens long associated with inflammatory disease are able to slow the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease. by dysregulating activity of the VDR nuclear receptorIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affects transcription.. This facilitates the ability of other species to gradually accumulate in tissue and blood, where they generate proteins and metabolites that significantly interfere with the body’s metabolic processes. The microbes that contribute to this dysfunction are often inherited from family members. Immunosuppressive therapies for inflammatory disease allow pathogens driving these processes to spread with greater ease. In contrast to immunosuppression, treatments that stimulate the immune system seem to allow for reversal of this pathogen-induced genomic dysregulation.

home/publications/proal_discoverymedicine_2014.txt · Last modified: 07.18.2016 by joyful
© 2015, Autoimmunity Research Foundation. All Rights Reserved.